Skip to content

The combination effect of five herbal drugs" Peganum harmala, Quercus infectoria,Vaccinium myrtillus, Citrullos colocynthis, Securigera securidaca" on blood glucose in adults with type 2 diabetes mellitus

The combination effect of five herbal drugs" Peganum harmala,Quercus infectoria,Vaccinium myrtillus, Citrullos colocynthis, Securigera securidaca" on blood glucose in adults with type 2 diabetes mellitus

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT138811143180N1
Enrollment
20
Registered
2010-06-06
Start date
2009-08-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes mellitus. Non-insulin-dependent diabetes mellitus

Interventions

Intervention 1: Intervention group: capsule contains 500 mg of combination of 5 herbal drug, twice daily for 8 weeks. Intervention 2: Placebo group: flour of bean capsul, twice daily for 8 weeks.
Treatment - Drugs
Placebo
Intervention group: capsule contains 500 mg of combination of 5 herbal drug, twice daily for 8 weeks

Sponsors

Mazandaran University of Medical Sciences and Health
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age 30 to 80, HbA1C 6.5 to 8% .Exclusions criteria: Immune deficiency, pregnancy and lactation, cardiovascular disease, currently receiving corticosteroids and thiazide, uncontrolled thyroid dysfunction, acute infection ,history of diabetic ketoacidosis , Cr>1.5 for male, Cr>1.2 for female, acute hepatitis, cirrhosis, proliferative retinopathy and severe weight loss (at least 10% during last 6 months)

Exclusion criteria

Exclusion criteria:

Design outcomes

Secondary

MeasureTime frame
Serum insulin. Timepoint: before and 8 weeks after intervention. Method of measurement: laboratory.;Lipid profile. Timepoint: before and 4 and 8 weeks after intervention. Method of measurement: laboratory.;Weight. Timepoint: before and 8 weeks after intervention. Method of measurement: weight Scale.

Primary

MeasureTime frame
HbA1C. Timepoint: before and 8 weeks after intervention. Method of measurement: laboratory.;FBS. Timepoint: before and 4 and 8 weeks after intervention. Method of measurement: laboratory.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Kashi

Mazandaran University of Medical Sciences and Health

zkashi@mazums.ac.ir+98 15122617014

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026